BioSpace News Archive

Service Corporation International announced that its Board of Directors has approved a quarterly cash dividend of eighteen cents per share of common stock.

CONCEPT Professional Training at Palo Alto University, a global leader in online professional training in forensic mental health, is hosting its Summer Training Institute 2019 at Palo Alto University, June 17 to 21.

Industry commercialization veteran to lead next phase of Inagene’s growth.

Consumption of company’s sweeteners improved glucose tolerance in mice

Columbia Care Inc. (“Columbia Care”, or the “Company”) (NEO: CCHW), today announced preliminary revenue and gross profit results for the quarter ended March 31, 2019, as well as the year ended December 29, 2018.

Bridgecom, provider of the standardized colorectal cancer (CRC) screening outreach program to accelerate patient compliance, announced today its acceptance as a corporate associate member of the National Colorectal Cancer Roundtable (NCCRT)

DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today provided an update to stockholders regarding the Company’s rights offering and the key dates and terms relative to the offering.

Digicom features its ROACH System and EMS Aerospace Capabilities at Space Tech Expo, Booth 4023

Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, will release its financial results for the first quarter of 2019 on Wednesday, May 15, 2019, after the close of the U.S. financial markets.

AstraZeneca and Merck’s Lynparza reduced the risk of disease progression or death by 70% compared to placebo following response to platinum-based chemotherapy